NCT03626688 A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients Status COMPLETED Phase PHASE3
NCT03612115 Neuromuscular Electrical Stimulation in Pulmonary Arterial Hypertension Status COMPLETED Phase NA
NCT03602781 Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric Status WITHDRAWN Phase PHASE3
NCT03556020 Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH Status TERMINATED Phase PHASE2
NCT03554330 Combined Use of Radiofrequency-ablation and Balloon-septostomy in the Creation of a Stable Inter-atrial Communication Status UNKNOWN Phase NA
NCT03554291 Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension Status COMPLETED Phase PHASE2
NCT03550729 Effects of Physical Training on Vascular Function as a Therapeutic Target in Pulmonary Hypertension Status ACTIVE_NOT_RECRUITING Phase NA
NCT03497689 EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE4
NCT03496207 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) Status COMPLETED Phase PHASE2
NCT03492177 A Clinical Study of to Confirm the Doses of Selexipag in Children With Pulmonary Arterial Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03476629 Effects of Different Types of Physical Training in Patients With Pulmonary Arterial Hypertension. Status UNKNOWN Phase NA
NCT03464864 Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers Status COMPLETED Phase PHASE1
NCT03422328 A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies. Status COMPLETED Phase PHASE3
NCT03401476 Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension Status UNKNOWN Phase PHASE2